13.5 Enzyme Kinetics: Michaelis-Menten Model, Lineweaver-Burk Analysis, and Enzyme Inhibition

13.5 Enzyme Kinetics: Michaelis-Menten Model, Lineweaver-Burk Analysis, and Enzyme Inhibition

Quick Answer: Enzymes accelerate biochemical transformations by lowering the activation energy barrier ($\Delta G^\ddagger$) through preferential binding and stabilization of the transition state ($S^\ddagger$). They leave the thermodynamic equilibrium constant ($K_{\text{eq}}$) and standard free energy change ($\Delta G^\circ$) completely unaltered. In chymotrypsin, the catalytic triad (Asp102-His57-Ser195) coordinates nucleophilic attack, with the oxyanion hole stabilizing the negative charge on the tetrahedral intermediates. The Michaelis-Menten equation, $v_0 = \frac{V_{\text{max}}[S]}{K_m + [S]}$, derived under the Briggs-Haldane steady-state approximation ($\frac{d[ES]}{dt} = 0$), defines $K_m$ as the substrate concentration at half-maximal velocity ($v_0 = \frac{1}{2}V_{\text{max}}$). Catalytic efficiency is expressed as $k_{\text{cat}}/K_m$, with a diffusion-controlled ceiling of $10^8 - 10^9\text{ M}^{-1}\text{s}^{-1}$. Double-reciprocal Lineweaver-Burk plots diagnostic for inhibition reveal: competitive inhibition increases apparent $K_m$ ($V_{\text{max}}$ unchanged; lines intersect at $y$-axis), uncompetitive inhibition decreases both $V_{\text{max}}$ and $K_m$ equally (parallel lines), and non-competitive inhibition decreases $V_{\text{max}}$ ($K_m$ unchanged; lines intersect at negative $x$-axis).

---

Principles of Enzymatic Catalysis and Transition State Theory

Enzymes are stereospecific macromolecular catalysts—predominantly proteins, alongside catalytic RNAs (ribozymes)—that accelerate chemical reaction rates by factors of $10^6$ to $10^{17}$ under mild physiological conditions ($1\text{ atm}$, $37^\circ\text{C}$, $\text{pH } 7.0-7.4$).

Free Energy Profile of Uncatalyzed vs. Enzymatically Catalyzed Reactions:

 Free  ^
 Energy|             ‡ (Uncatalyzed Transition State, high ΔG‡_uncat)
   G   |            / \
       |           /   \           ‡ (Catalyzed Transition State, lower ΔG‡_cat)
       |          /     \         / \
       |   S ----+       \       /   \ 
       |  (Substrate)     \  ES-+     \   P (Product)
       |                   \           \-/
       |                    \-----------/
       +---------------------------------------------> Reaction Coordinate
             |<-------- ΔG° remains unchanged ------->|

Thermodynamic Invariants

To master licensure enzyme questions, remember these core thermodynamic principles:

1. Activation Energy: Enzymes lower the Gibbs free energy of activation ($\Delta G^\ddagger$). According to the transition state equation ($k = \frac{k_B T}{h} e^{-\Delta G^\ddagger / RT}$), reducing $\Delta G^\ddagger$ exponentially accelerates the rate constant ($k$).
2. Equilibrium Invariance: Enzymes do NOT alter the reaction equilibrium constant ($K_{\text{eq}}$) or the net standard free energy change of the reaction ($\Delta G^\circ$). They accelerate the forward rate ($k_1$) and reverse rate ($k_{-1}$) by the exact same factor: $K_{\text{eq}} = \frac{k_1}{k_{-1}} = \text{constant}$.
3. Transition State Complementarity: In 1946, Linus Pauling postulated that an enzyme's active site is not complementary to the ground-state substrate (the historic Fischer "lock-and-key" model), but rather is stereochemically and electronically complementary to the transition state ($S^\ddagger$). If an enzyme bound the ground-state substrate too tightly, it would fall into a thermodynamic "trough," increasing the activation barrier. By maximizing non-covalent binding interactions (hydrogen bonds, electrostatic contacts, van der Waals dispersion) exclusively at the transition state, the enzyme releases binding energy ($\Delta G_B$) that offsets the activation barrier.

Primary Catalytic Mechanisms

Enzymes combine four major catalytic strategies:

• General Acid-Base Catalysis: Transfer of protons mediated by ionizable amino acid side chains. Unlike specific acid-base catalysis (which depends solely on hydronium $H_3O^+$ or hydroxide $OH^-$ from the solvent), general acid-base catalysis uses active-site residues (His imidazole, Asp/Glu carboxylates, Lys amino, Cys thiol) that donate or abstract protons at rates faster than water ionization.
• Covalent Catalysis: Formation of a transient, high-energy covalent linkage between a nucleophilic residue on the enzyme and an electrophilic center on the substrate (e.g., acyl-enzyme intermediates in chymotrypsin; Schiff base imine intermediates in aldolases).
• Metal Ion Catalysis: Bound cofactors ($Zn^{2+}, Mg^{2+}, Fe^{2+}, Mn^{2+}$) stabilize developing negative charges on transition states, mediate oxidation-reduction electron transfers, or polarize coordinated water molecules to generate potent nucleophiles at neutral pH. For example, $Zn^{2+}$ in carbonic anhydrase lowers the $pK_a$ of water from $15.7$ to $7.0$, producing an active nucleophilic hydroxide ($OH^-$) that attacks $CO_2$ to form $HCO_3^-$ at turnover rates exceeding $10^6\text{ s}^{-1}$.
• Proximity and Orientation Effects: The active site freezes out the translational and rotational degrees of freedom of substrates, aligning reactive orbitals in optimal geometries with negligible conformational entropy loss in the transition state.

---

The Serine Protease Mechanism: Catalytic Triad and Oxyanion Hole

Chymotrypsin, trypsin, and elastase are classic endopeptidases that hydrolyze interior peptide bonds via a nucleophilic serine mechanism.

Architecture of the Chymotrypsin Catalytic Triad:

    Asp 102               His 57                  Ser 195
     O                 H                       H
     |                 |                       |
   --C--O^-  ·······  N-δ--Imidazole--N-ε: ···· O--CH2--
     |                                         |
   (Carboxylate)      (General Base/Acid)   (Nucleophile)
   [ Polarizes His ]  [ Proton Shuttle ]    [ Attacks Carbonyl ]

The Catalytic Triad

The active site features three invariant residues linked by a precise hydrogen-bonding network:

1. Aspartate 102: Buried in a low-dielectric hydrophobic pocket; its carboxylate group forms a hydrogen bond with His57, immobilizing it and polarizing its imidazole ring to increase its basicity.
2. Histidine 57: Acts sequentially as a general base (abstracting a proton from Ser195) and as a general acid (donating a proton to the leaving group).
3. Serine 195: The primary nucleophile. Deprotonation converts its primary alcohol into an exceptionally reactive, alkoxide-like nucleophile ($-\text{CH}_2-\text{O}^-$).

The Step-by-Step Catalytic Cycle

1. Substrate Binding: The polypeptide substrate docks into the active site. In chymotrypsin, the bulky aromatic side chain (Phe, Trp, Tyr) slips into a deep, hydrophobic $S_1$ specificity pocket.
2. Nucleophilic Attack & Tetrahedral Intermediate 1: His57 acts as a general base, abstracting the proton from the Ser195 hydroxyl group. The activated Ser195 oxygen attacks the carbonyl carbon of the scissile peptide bond. The planar $sp^2$ carbonyl carbon rehybridizes into a tetrahedral $sp^3$ intermediate carrying a negative charge on the carbonyl oxygen (oxyanion).
3. Transition State Stabilization in the Oxyanion Hole: The developing negative charge on the tetrahedral oxygen is stabilized by hydrogen bonds donated from the backbone amide $N-H$ groups of Glycine 193 and Serine 195. These hydrogen bonds form only in the tetrahedral transition state, not in the planar ground state, accelerating catalysis by a factor of $>10^4$.
4. Acyl-Enzyme Formation (Collapse of Intermediate 1): His57 acts as a general acid, donating a proton to the nitrogen atom of the scissile peptide bond. The tetrahedral intermediate collapses, cleaving the peptide linkage: the newly liberated C-terminal peptide fragment departs, leaving the N-terminal portion covalently bonded to Ser195 as an acyl-enzyme intermediate.
5. Deacylation by Water: A water molecule enters the vacated active site. His57 acts as a general base, abstracting a proton from water. The resulting hydroxide ion ($OH^-$) attacks the carbonyl carbon of the acyl-enzyme intermediate.
6. Tetrahedral Intermediate 2: Rehybridization generates a second tetrahedral $sp^3$ intermediate, again electrostatically stabilized by the oxyanion hole.
7. Product Release and Triad Regeneration: His57 acts as a general acid, donating its proton back to the oxygen of Ser195. The ester bond collapses, releasing the N-terminal peptide fragment with a newly created free carboxylate group. The catalytic triad returns to its ground state, ready for another cycle.

---

Michaelis-Menten Kinetics: Steady-State Model and Parameters

In 1913, Leonor Michaelis and Maud Menten proposed a kinetic model based on rapid reversible substrate binding followed by a slow catalytic conversion step. In 1925, G. E. Briggs and J. B. S. Haldane generalized this treatment using the steady-state approximation.

Reaction Scheme:
          k1          k2
   E + S <===> ES --------> E + P
          k-1       (kcat)

The Briggs-Haldane Steady-State Derivation

1. Let $[E]_t$ represent total enzyme concentration, $[E]$ free enzyme, $[S]$ free substrate concentration, and $[ES]$ the enzyme-substrate complex: $[E] = [E]_t - [ES]$.
2. The Steady-State Assumption: Shortly after mixing, the concentration of the intermediate $[ES]$ reaches a dynamic steady state where its rate of formation equals its rate of breakdown:

$\frac{d[ES]}{dt} = 0$ $\text{Rate of } [ES] \text{ formation} = k_1 [E][S] = k_1 ([E]_t - [ES])[S]$ $\text{Rate of } [ES] \text{ breakdown} = (k_{-1} + k_2)[ES]$

1. Equating formation and breakdown:

$k_1 ([E]_t - [ES])[S] = (k_{-1} + k_2)[ES]$ $k_1 [E]_t [S] - k_1 [ES][S] = (k_{-1} + k_2)[ES]$ $k_1 [E]_t [S] = (k_{-1} + k_2 + k_1 [S])[ES]$ $[ES] = \frac{k_1 [E]_t [S]}{(k_{-1} + k_2) + k_1 [S]} = \frac{[E]_t [S]}{\left(\frac{k_{-1} + k_2}{k_1}\right) + [S]}$

1. Defining the Michaelis Constant ($K_m$):

$K_m = \frac{k_{-1} + k_2}{k_1}$

1. Initial velocity is governed by product formation ($v_0 = k_2 [ES]$), and maximal velocity occurs when the enzyme is completely saturated ($V_{\text{max}} = k_2 [E]_t$):

$v_0 = \frac{k_2 [E]_t [S]}{K_m + [S]} = \frac{V_{\text{max}}[S]}{K_m + [S]}$

Hyperbolic Michaelis-Menten Velocity Profile:

  Velocity ^
    v0     |
   Vmax ---+-----------------------------------
           |                     ..................
  1/2 Vmax - - - - - - - - - - -/
           |                 .  :
           |              .     :
           |          .         :
           |       .            :
           +------+-------------+--------------> [S] Substrate Concentration
           0     Km

Kinetic Constants and Their Diagnostic Meanings

Limiting Kinetic Regimes

• Low Substrate ($[S] \ll K_m$): The denominator $K_m + [S] \approx K_m$. The rate law simplifies to $v_0 = \left(\frac{V_{\text{max}}}{K_m}\right)[S] = \left(\frac{k_{\text{cat}}}{K_m}\right)[E]_t [S]$. Kinetics are first-order with respect to substrate.
• Saturating Substrate ($[S] \gg K_m$): The denominator $K_m + [S] \approx [S]$. The rate law simplifies to $v_0 = \frac{V_{\text{max}}[S]}{[S]} = V_{\text{max}}$. Kinetics are zero-order with respect to substrate; rate is independent of $[S]$.

Worked Quantitative Kinetics Problem

Problem: An enzyme-catalyzed reaction with $[E]_t = 2.0\text{ nM}$ ($2.0 \times 10^{-9}\text{ M}$) exhibits $V_{\text{max}} = 1.2\text{ }\mu\text{M}\cdot\text{s}^{-1}$ ($1.2 \times 10^{-6}\text{ M}\cdot\text{s}^{-1}$) and $K_m = 40\text{ }\mu\text{M}$ ($4.0 \times 10^{-5}\text{ M}$).

1. Calculate the turnover number ($k_{\text{cat}}$): $k_{\text{cat}} = \frac{V_{\text{max}}}{[E]_t} = \frac{1.2 \times 10^{-6}\text{ M}\cdot\text{s}^{-1}}{2.0 \times 10^{-9}\text{ M}} = 600\text{ s}^{-1}$
2. Calculate the catalytic efficiency ($k_{\text{cat}}/K_m$): $\frac{k_{\text{cat}}}{K_m} = \frac{600\text{ s}^{-1}}{4.0 \times 10^{-5}\text{ M}} = 1.5 \times 10^7\text{ M}^{-1}\text{s}^{-1}$ (This enzyme approaches the diffusion-controlled limit of $10^8-10^9\text{ M}^{-1}\text{s}^{-1}$).
3. Determine initial velocity when $[S] = 10\text{ }\mu\text{M}$: $v_0 = \frac{V_{\text{max}}[S]}{K_m + [S]} = \frac{(1.2\text{ }\mu\text{M}\cdot\text{s}^{-1})(10\text{ }\mu\text{M})}{40\text{ }\mu\text{M} + 10\text{ }\mu\text{M}} = \frac{12}{50} = 0.24\text{ }\mu\text{M}\cdot\text{s}^{-1}$

---

Graphical Linearization: Lineweaver-Burk and Alternative Plots

Because non-linear hyperbolic curves make accurate visual determination of $V_{\text{max}}$ and $K_m$ difficult, kinetic data are linearized:

Lineweaver-Burk Double-Reciprocal Plot:

    1/v0 ^
         |           / (Slope = Km / Vmax)
         |          /
         |         / 
  1/Vmax +--------+  (y-intercept = 1 / Vmax)
         |       / 
         |      /   
         |     /
  -------+----+-------------------------> 1/[S]
 -1/Km   |    0
 (x-intercept = -1/Km)

Mathematical Formulation of Linear Plots

1. Lineweaver-Burk (Double-Reciprocal) Plot: Taking the reciprocal of both sides of the Michaelis-Menten equation:

$\frac{1}{v_0} = \frac{K_m + [S]}{V_{\text{max}}[S]} = \left(\frac{K_m}{V_{\text{max}}}\right)\frac{1}{[S]} + \frac{1}{V_{\text{max}}}$

• $y$-variable: $\frac{1}{v_0}$
• $x$-variable: $\frac{1}{[S]}$
• Slope: $\frac{K_m}{V_{\text{max}}}$
• $y$-intercept: $\frac{1}{V_{\text{max}}}$ (set $\frac{1}{[S]} = 0$)
• $x$-intercept: $-\frac{1}{K_m}$ (set $\frac{1}{v_0} = 0$)

1. Eadie-Hofstee Plot: $v_0 = -K_m \left(\frac{v_0}{[S]}\right) + V_{\text{max}}$. Plotting $v_0$ vs. $v_0/[S]$ yields slope $= -K_m$, $y$-intercept $= V_{\text{max}}$, and $x$-intercept $= V_{\text{max}}/K_m$. Does not disproportionately weight data at low $[S]$.
2. Hanes-Woolf Plot: $\frac{[S]}{v_0} = \left(\frac{1}{V_{\text{max}}}\right)[S] + \frac{K_m}{V_{\text{max}}}$. Plotting $[S]/v_0$ vs. $[S]$ yields slope $= \frac{1}{V_{\text{max}}}$, $y$-intercept $= \frac{K_m}{V_{\text{max}}}$, and $x$-intercept $= -K_m$.

---

Reversible Enzyme Inhibition

Reversible inhibitors bind non-covalently to enzymes, establishing rapid thermodynamic equilibria. They are categorized based on whether they bind to free enzyme ($E$), the enzyme-substrate complex ($ES$), or both:

$\alpha = 1 + \frac{[I]}{K_I} \quad \text{and} \quad \alpha' = 1 + \frac{[I]}{K_I'}$

Where $K_I = \frac{[E][I]}{[EI]}$ and $K_I' = \frac{[ES][I]}{[ESI]}$.

Double-Reciprocal Profiles of Reversible Inhibition:

 Competitive: (Cross at y-axis)       Uncompetitive: (Parallel lines)      Non-competitive: (Cross at x-axis)
      1/v0 ^       + Inhibitor              1/v0 ^       + Inhibitor             1/v0 ^       + Inhibitor
           |      /                              |      /                             |      /
           |     /                               |     /                              |     /  
    1/Vmax +----+  Control                1/Vmax +----+  Control               1/Vmax +----+  Control
           |   /                                 |   /                                |   / 
  ---------+--+----------> 1/[S]       ----------+--+----------> 1/[S]      ----------+--+----------> 1/[S]
           |  0                                  |  0                              -1/Km 0

---

Irreversible Inhibition and Suicide Inactivators

Irreversible inhibitors (inactivators) chemically destroy or covalently modify functional catalytic groups in the active site, resulting in permanent loss of enzymatic activity. They cannot be dissociated by dilution or prolonged dialysis.

Classic Irreversible Inhibitor Systems

1. Organophosphates (DFP and Nerve Agents): Diisopropyl fluorophosphate (DFP), Sarin, and agricultural organophosphate insecticides (Malathion, Parathion) contain a labile phosphoryl-fluoride or phosphorothioate bond. The active-site Ser195 of acetylcholinesterase (AChE) attacks the phosphorus atom, releasing fluoride and forming an extremely stable, covalent diisopropylphosphoryl-serine ester. This blocks the breakdown of acetylcholine at neuromuscular junctions, causing continuous cholinergic stimulation, muscle fasciculations, respiratory arrest, and death.
   • Antidote Mechanism: Pralidoxime (2-PAM) is a strong nucleophile with a quaternary pyridinium nitrogen that docks near the AChE anionic subsite. Its oxime group ($-\text{CH}=\text{N}-\text{OH}$) attacks the phosphorus atom, cleaving the covalent organophosphate bond and regenerating active AChE, provided administration occurs before aging (dealkylation of the organophosphate).
2. Penicillin and $\beta$-Lactam Antibiotics (Suicide Inhibition): Bacterial transpeptidase (penicillin-binding protein) cross-links peptide chains during peptidoglycan cell-wall synthesis by recognizing a terminal $-\text{D}-\text{Ala}-\text{D}-\text{Ala}$ dipeptide. Penicillin acts as a suicide (mechanism-based) inhibitor: its strained four-membered $\beta$-lactam ring mimics the transition state of $-\text{D}-\text{Ala}-\text{D}-\text{Ala}$. The catalytic Ser hydroxyl attacks the $\beta$-lactam carbonyl, opening the ring to form a stable penicilloyl-enzyme conjugate that cannot be hydrolyzed, arresting bacterial cell-wall construction and inducing osmotic lysis.
3. Aspirin (Acetylsalicylic Acid): Irreversibly inactivates cyclooxygenase-1 (COX-1) by covalently transferring its acetyl group to Serine 530, located near the catalytic pocket. Acetylation sterically blocks the entry of arachidonic acid, shutting down thromboxane $A_2$ synthesis in platelets for their entire 10-day lifespan.

---

Allosteric Enzymes and Cooperative Kinetics

Not all enzymes follow hyperbolic Michaelis-Menten kinetics. Allosteric enzymes are oligomers with multiple active sites that display sigmoidal (S-shaped) velocity curves ($v_0$ vs. $[S]$).

Allosteric Sigmoidal Curve and Effector Modulations:

 Velocity ^
   v0     |               + Positive Allosteric Effector (Activator, shifts curve LEFT to R-state)
          |            .--'
     Vmax |         .-'   -- Base Sigmoidal Curve (Cooperative, Hill nH > 1)
          |       .'    .-
          |      /    .'    + Negative Allosteric Effector (Inhibitor, shifts curve RIGHT to T-state)
          |     /   .'    .'
          |    /  .'   .-'
          +---+--+----+------------------------> [S]
          0   K0.5

Theoretical Models: MWC vs. KNF

• Monod-Wyman-Changeux (MWC) Concerted Model: The enzyme exists in an equilibrium between two distinct conformational states: the T-state (Tense), which has low substrate affinity, and the R-state (Relaxed), which has high substrate affinity. All subunits change conformation simultaneously in a concerted "all-or-none" transition. Substrate binding shifts the equilibrium toward the R-state.
• Koshland-Némethy-Filmer (KNF) Sequential Model: Substrate binding to one subunit induces a local conformational change that alters the binding affinity of adjacent subunits sequentially via an induced-fit mechanism.

The Hill Equation and Coefficient ($n_H$)

Cooperativity is quantified using the Hill Equation:

$\log\left(\frac{\theta}{1 - \theta}\right) = n_H \log[S] - \log K_{0.5}$

Where $\theta = v_0 / V_{\text{max}}$ is fractional active site saturation, and $n_H$ is the Hill coefficient:

• $n_H = 1$: Non-cooperative binding; hyperbolic Michaelis-Menten kinetics.
• $n_H > 1$: Positive cooperativity; binding of substrate to one subunit enhances affinity of remaining subunits (e.g., hemoglobin, $n_H \approx 2.8-3.0$; ATCase, $n_H \approx 2.5$).
• $n_H < 1$: Negative cooperativity; binding of substrate decreases affinity of remaining subunits.

Allosteric Systems: $K$-Systems vs. $V$-Systems

• $K$-Systems: Allosteric effectors alter the apparent affinity constant ($K_{0.5}$ or $[S]_{0.5}$) without changing $V_{\text{max}}$. Activators shift the sigmoidal curve to the left (decreasing $K_{0.5}$); inhibitors shift it to the right (increasing $K_{0.5}$). Case Study: Aspartate Transcarbamoylase (ATCase) catalyzes the first committed step of pyrimidine biosynthesis ($carbamoyl \text{ phosphate} + L-aspartate \rightarrow N-carbamoylaspartate$). It is allosterically activated by ATP (a purine, signaling energy abundance and nucleotide balance) and feedback-inhibited by CTP (a pyrimidine end-product).
• $V$-Systems: Allosteric effectors alter $V_{\text{max}}$ without modifying $K_{0.5}$.